Ledger.Open graph →

SEC Form D · Amendment · filed February 22, 2021

Cage Bio, Inc

Offering

$9.8M

Sold

$9.4M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN CARLOS, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Ravi Srinivasan · Dallas, TXExec · Director Samir Mitragotri · San Carlos, CADirector Nitin Joshi · San Carlos, CAExec · Director Tom Shen · Westwood, MAExec · Director Nathan Baumeister · Westwood, MAExec · Director Jay Tuli · Westwood, MADirector Martin K. Reed · Vancouver, British Columbia, CanadaExec · Director John W. Watson · Vancouver, British Columbia, CanadaDirector Elizabeth Greenwood · Santa Monica, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗